Uncategorised - European Medical Journal

Infant Bronchiolitis May Cause Lasting Lung Damage

Young adults who experienced bronchiolitis in infancy may face irreversible airway obstruction, according to new research linking early-life respiratory illness with long-term lung impairment.

New Guidelines Aim to Transform Duchenne Orthopedic Care

A newly developed UK consensus guideline outlines critical recommendations for the orthopedic management of children and young people with Duchenne muscular dystrophy (DMD), addressing an urgent need for standardized fracture and surgical care.

Allergic Rhinitis Increases Risk of Depression and Anxiety

The study suggests that the inflammatory processes central to AR may also affect the brain, potentially leading to mood disturbances through mechanisms such as elevated cytokines or histamine imbalance.

Combination Therapy Shows Promise in ‘Cold’ Soft Tissue Sarcoma Trial

A new clinical trial offers insight into tackling one of the biggest challenges in soft tissue sarcomas….

Europe Urged to Improve Newborn Biliary Atresia Screening

Biliary atresia is the most common surgical cause of cholestatic jaundice in infants and the leading reason for paediatric liver transplants

Saliva Testing Identifies Early Risk for Cancer and Chronic Diseases

Saliva-based DNA markers could predict cancer, heart disease, and more—offering a non-invasive future for early diagnosis.

Could Skincare and Bathing Practices Be Fueling Atopic Dermatitis?

A new perspective on atopic dermatitis suggests that disruptions to the skin’s microbial ecosystem and routine bathing practices may play a larger role in the disease’s origin and progression than previously recognized.

AI Enhances Efficiency and Accuracy in Tumour Biomarker Testing

A new study highlights the clinical promise of AI-driven IHC prediction models, showing high accuracy and diagnostic concordance with conventional pathology.

MVA-BN Vaccine Offers Safe Mpox Protection in At-Risk Groups

A German multicentre study shows MVA-BN vaccination is safe and moderately effective in preventing mpox, especially in HIV-negative individuals.

Dupilumab Linked to Increased Psoriasis Risk in Atopic Dermatitis

Given dupilumab’s well-documented benefits in controlling moderate to severe AD, clinicians are advised to weigh this potential risk carefully against its therapeutic advantages.